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Abstract Previous studies have shown that sphingolipids may be 
enriched in caveolae, plasmalemmal invaginations implicated in 
endocytosis and signal transduction. We synthesised a radio- 
labeled derivative of ganglioside GM1 bearing a photo-reactive 
cross-linker at the end of its acyl chain. After insertion in the 
plasma membrane of cultured A431 or MDCK cells and photoac- 
tivation, the main protein cross-linked by the GM1 derivative was 
VIP21-caveolin, an essential structural component of caveolae. 
This result shows close proximity between GM1 molecules and 
VIP21-caveolin in the caveolar membrane and strongly impli- 
cates sphingolipid segregation in the biogenesis of caveolae. 
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1. Introduction 
Caveolae are specialised plasma membrane invaginations 
with defined size and morphology [1]. Although traditionally 
described as non-coated pits, caveolae bear on their cytoplas- 
mic side a coat-like array of filaments revealed by non-conven- 
tional electron microscopy techniques [2,3]. In contrast to other 
coat structures uch as the clathrin lattice, the caveolar coat 
seems insensitive to treatments that strip peripheral compo- 
nents from membranes [4]. VIP21-caveolin, a membrane pro- 
tein originally identified as a major substrate of the v-Src kinase 
[5], is localized in caveolae [4,6-8]. Immunofluorescence studies 
showed that both the N- and the C-terminus of the protein are 
cytosolic while the central hydrophobic region forms a hairpin- 
structure within the membrane [8]. This unique topology has 
been recently confirmed [9]. Several independent observations 
indicate that VIP21-caveolin plays a structural role in caveolae, 
probably as a component of their coat. First, VIP21-caveolin 
has been localised by immunogold staining on the coat fila- 
ments detected by freeze-etch electron microscopy [4]. Second, 
VIP21-caveolin forms high molecular weight complexes resis- 
tant to detergent solubilisation [9]. Third, the density of the 
protein in the caveolar membrane, estimated by immunogold 
electron microscopy, is extremely high [8,10]. Finally, expres- 
sion of VIP21-caveolin in lymphocytes lacking the protein in- 
duces de novo formation of caveolae [10]. 
A very interesting feature of caveolae is the organisation of 
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their lipid bilayer, which seems to differ from that of the sur- 
rounding plasma membrane. After cell extraction with non- 
ionic detergents at low temperature, VIP21-caveolin is found 
in low-density complexes in association with cholesterol and 
sphingolipids [11,12]. Cholesterol is required for the integrity 
of caveolae since sterol-binding drugs such as nystatin or filipin 
disorganise the coat morphology [4]. A concentration f gangli- 
osides in caveolae has been also revealed by electron micros- 
copy studies using tetanus toxin and cholera toxin B subunit 
(CTB) as specific ligands [13,14]. Interestingly, enrichment of 
the monosialoganglioside GM1 in caveolae was greatly en- 
hanced by adding the pentavalent CTB to cells [14], probably 
due to a clustering effect similar to that suggested for GPI- 
anchored proteins [15]. 
In this study, we make use of a photoreactive derivative of 
ganglioside GM1 as a probe to investigate glycolipid-protein 
interactions within the plasma membrane of living MDCKI I  
and A431 cells. 
2. Materials and methods 
2.1. Chemicals 
Cholera toxin B subunit was purchased from Sigma. Recombinant 
CTB, free of subunit A, was kindly provided by Dr. R. Rappuoli 
(Biocine, Siena, Italy). GM1 ganglioside was extracted from bovine 
brain according to [16] and characterised aspreviously described [17]. 
NaB[3H]4 was purchased from Amersham. 
2.2. Synthesis of [JH]GMI(N3) 
The radioactive and photoactivatable derivative of GM 1 ganglioside 
([3H]GM 1 (N3)) was prepared from natural GM 1 ganglioside according 
to the following steps. GM1 was converted into lyso-GM1 by specific 
alkaline hydrolysis [18]. Lyso-GM1 was then acylated with disuccin- 
imidyl carbonate-activated aminododecanoic acid according to [19] and 
tritium labeled at position 6 of terminal galactose by the galactose 
oxidase/NaB[3H]4 procedure [20] modified as follows. 20 mg of GM1 
derivative were suspended in 15 ml Tris-HC150 mM, pH 7.4, containing 
250 mg Triton X-100. After addition of 1200 U galactose oxidase and 
overnight incubation at37°C, the oxidised GM 1 derivative was purified 
on a Kieselgel 100 column (100 x 1.5 cm), equilibrated and eluted with 
chloroform/methanol/water, 60:35 :5 (v/v/v). The elution profile was 
monitored by TLC. Reduction of the oxidised GM1 derivative with 
NaB[3H]4 (500 mCi, 70 Ci/mmol) was performed in 1.5 ml propanol/ 
water, 7:3 (v/v). The reaction mixture containing the tritium labeled 
GM 1 derivative was then applied on a Sep-Pak C 18 cartridge, washed 
with 20 ml water and eluted with methanol. Introduction of the pho- 
toactivable nitrophenylazide on the terminal amino group of the acyl 
chain was performed as described previously [19]. The final specific 
activity of [3H]GMI(N3) was 15 Ci/mmol. Before the cross-linking 
experiments the solvent was evaporated and the photo-reactive GM1 
resuspended in MEM-10 mM HEPES (MEM-H). 
2.3. Cross-linking experiments 
A431 and MDCKII cells were culturecl as previously described [8]. 
For the incorporation of the ganglioside analogue into the plasma 
membrane, 80-90% confluent cells in 10-cm dishes were washed with 
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MEM-H and incubated for 3 h at 8°C with 2.5 ml of the same medium 
containing 6#M [3H]GMI(N3). After removal of the unincorporated 
ganglioside, unspecific binding was minimised by washing the cells for 
30 min at 8°C with MEM-H/0.2% BSA [21]. When indicated, cells were 
further treated at 8°C with 3 #g/ml CTB in MEM-H/0.2% BSA. All the 
above incubations were performed in the dark. The cells were then 
washed with ice-cold PBS, irradiated for 10 min on ice with an UV lamp 
at 366 nm, scraped and homogenised by sonication in 500 #1 Tris-HC1 
10 raM, pH 7.4. The cell homogenate was brought o 1.5 M sucrose, 
transferred to a centrifuge tube and overlayed with 8.5 ml of 1.2 M and 
2.5 ml of 0.8 M sucrose in Tris-HCl 10 mM, pH 7.4. After flotation for 
18 h at 250,000 x g, 4°C, membranes atthe 0.8/1.2 M sucrose interface 
fraction were diluted two-fold and pelleted for 1 h at 230,000 x g. The 
pellet was either treated for immunoprecipitation as below or directly 
solubilised in lysis buffer [22] for 2D gel analysis. 
For the in vitro cross-linking of the GM1 probe, 200 #1 of 6 #M 
[3H]GMI(N3) in MEM-H, either alone or in the presence of 3 #g/ml 
CTB, were photo-activated at 366 nm for 10 min. After precipitation 
with 90% ice-cold acetone, the pellet was solubilised for 30 min at 37°C 
in lysis buffer for 2D gel analysis. 
2.4. Immunoprecipitation of VIP21-caveolin 
Membranes prepared as described above were solubilised at 37°C for 
20 min in 500#1 of the following buffer: 25 mM Tris, pH 7.4, 150 mM 
NaC1, 1% Triton X-100, 0.1% gelatin, and a mixture of protease inhib- 
itors containing 20 #g of chymostatin, leupeptin, antipain and pep- 
statin. The lysate was centrifuged at 3000 x g for 10 min and then 
incubated at 4°C for 1 h with affinity-purified rabbit anti-VIP21 anti- 
bodies against the N-terminal peptide 14~33 [8]. After Protein A Sepha- 
rose (PAS) was added, incubation was prolonged for 2 h at 4°C. The 
PAS beads were then washed and eluted at 37°C for 30 min in the lysis 
buffer for 2D gel analysis. 
2.5. 2D gel electrophoresis 
2D gels analysis was performed using the BioRad Mini-protean II
2D system according to the manufacturer's ecommendations, except 
for the first dimension mixture that was prepared as described in [22]. 
15% gels were used for the second dimension. For fluorography gels 
were enhanced with Entensify (Dupont) and exposed to X-omat films 
(Kodak). 
3. Results and discussion 
Our experimental strategy was designed to specifically inves- 
tigate ganglioside-protein teractions occurring within the 
plasma membrane. A radio-labeled photo-reactive GM 1 deriv- 
ative ([3H]GMI(N3)) was prepared by modifying the synthesis 
of an analogue previously used to probe for interacting proteins 
in fibroblasts and cerebellar granule cells [23,19]. In order to 
obtain a higher specific radioactivity, the reagent used here was 
labeled on the terminal galactose (Fig. 1). 
Since the cell surface distribution of endogenous GM1 had 
been thoroughly investigated by electron microscopy in A431 
fibroblasts [24,14], these cells were selected for the present 
study. Binding of [3H]GMI(N3) to cells and cross-linking were 
performed at 8°C to minimise endocytosis of the probe. No 
internalisation of GM 1 was detected by electron microscopy at 
this temperature [14]. By using 6/,tM [3H]GMI(N3) in the me- 
dium, 125 pmol photo-reactive GMl /mg protein were incorpo- 
rated over a 3 h incubation. After photoactivation f the probe, 
an enriched light membrane fraction was prepared which in- 
cluded both the plasma membrane and intracellular smooth 
membranes [12]. Analysis of the cross-linked molecules con- 
tained in this fraction by 2D gel electrophoresis demonstrated 
a remarkably simple pattern (Fig. 2a). Three radio-labeled pro- 
teins were visible in the 20-25 kDa range and another species 
was detectable in the upper right-end region of the gel. The 
same pattern was obtained when cells were incubated with CTB 
(Fig. 2b), a treatment known to favour localisation of GM 1 in 
caveolae [14]. The cross-linked proteins were not visible when 
the GM 1 suspension was photo-activated in vitro, either in the 
absence (Fig. 2c) or in the presence of CTB (Fig. 2d). Many low 
molecular weight products accumulated at the gel front, while 
high molecular weight material, including cross-linked CTB, 
did not enter the second dimension gel. A very similar pattern 
was observed in a subsequent experiment in which A431 fibro- 
blasts were compared to MDCKI I  epithelial cells (Fig. 3). 
The main cross-linked proteins in the 20 25 kDa range, indi- 
cated by arrowheads in Fig. 3, migrated as the VIP21-caveolin 
isoforms previously described in MDCKI I  cells [6]. To confirm 
the identity of these proteins, membranes derived from a cross- 
linking experiment performed on A431 cells were solubilised in 
Triton X-100 at 37°C and immunoprecipitated with anti- 
VIP21-caveolin antibodies. Indeed, the immunoprecipitated 
material analysed by 2D gel electrophoresis (Fig. 4) consists of 
the two VIP21-caveolin isoforms as well as of a VIP21-caveolin 
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Fig. 1. Structure of [3H]GMI(N3). Note the tritium labeling on the 
terminal galactose and the cross-linker position at the end of the acyl 
chain. 




Fig. 2. 2D gel analysis of proteins cross-linked by [3H]GMI(N3) in A431 cells, either in the absence (panel a) or in the presence of CTB (panel b). 
In vitro cross-linking of [3H]GM l(N3) , either alone (panel c) or with CTB (panel d), is presented for comparison. Specific ross- linked products are 
marked by arrows and arrowheads. Molecular weight markers: myosin, 200 kDa; phosphorylase B, 97.4 kDa; bovine serum albumine, 69 kDa; 
ovalbumin, 46 kDa; carbonic anhydrase, 30 kDa; lysozyme, 14.3 kDa. 
oligomer of over 200 kDa molecular weight. This oligomer, 
partially resistant to SDS treatment, has been described previ- 
ously [9]. As expected for the cross-linked proteins, the GM1- 
conjugated VIP21-caveolin forms are shifted to a higher molec- 
ular weight and a more acidic pI as compared to unmodified 
VIP21-caveolin. 
The selective cross-linking of VIP21-caveolin by the GM1 
analogue demonstrates a direct interaction of a ganglioside 
with VIP21-caveolin within the plasma membrane. Cholera 
toxin treatment seems to promote, but is not strictly required, 
for the cross-linking of GM 1 to VIP21-caveolin. Since GM 1 is 
also present in the plasma membrane areas between caveolae 
one has to assume that photoreative GM 1 is being cross-linked 
randomly to other plasma membrane proteins as well but that 
these do not show up in the 2D gel analysis because none of 
the proteins are sufficiently enriched in the vicinity of GM 1 
molecules. 
Previous studies have suggested that sphingolipids are en- 
riched in caveolae on the basis of co-purification of VIP21- 
caveolin with light detergent-insoluble complexes containing 
preferentially sphingolipids and cholesterol, as well as GPI- 
anchored proteins [6,11,12]. However, these studies did not 
specify whether the different components were in the same or 
distinct complexes. In fact the data available suggest hat the 
detergent-insoluble complexes derive from different cellular 
compartments. It is also important o point out that similar 
complexes have been isolated from cells lacking VIP21-caveolin 
and caveolae [25]. 
It has been shown that (glyco)sphingolipids and cholesterol 
undergo lateral phase separation i  lipid bilayers (reviewed in 
[26]). This segregation phenomenon could play a crucial role in 
caveolar biogenesis. Glycolipid clustering, known to strongly 
decrease membrane fluidity [27-29], could induce sphingomye- 
lin to co-segregate [30]. Given the known preference of sphin- 
gomyelin for cholesterol [31], this latter lipid would also associ- 
ate with the clusters. Proteins with a preference for one of these 





Fig. 3.2D gel analysis of proteins cross-linked by [3H]GM 1 (N3) in A431 
cells (panel a) compared to MDCKII cells (panel b), in the presence of 
CTB. The two spots indicated by arrowheads are putatively derived 
from cross-linking of isoforms of VIP21-caveolin. Molecular weight 
markers are as in Fig. 2. 
lipids could facilitate clustering and stabilize the lipid domain. 
Recent results demonstrate that VIP21-caveolin is a choles- 
terol-binding protein and may act as a stabilizer [32]. The pro- 
tein-bound cholesterol would associate with sphingolipids in- 
cluding GM 1 and thus increase the concentration of the latter 
lipids around VIP21-caveolin [33]. 
Finally, the detection of other labeled proteins beside VIP21- 
caveolin opens the possibility that these are also present in 
Fig. 4.2D gel analysis of VIP21-caveolin cross-linked by [3H]GMI(N3), 
immunoprecipitated from A431 cells by specific antibodies. The mon- 
omeric isoforms as well as the VIP21-caveolin oligomer are marked by 
arrowheads. Molecular weight markers are as in Fig. 2. 
caveolae and the cross-linking procedure described here may 
prove valuable for further analysis of caveolar components. 
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